Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go public on the Nasdaq Capital Market. The firm announced today the launch of its initial public offering of 6.67 million common shares.

The firm is targeting the share price between US$14.50 and US$15.50 per share, which puts target proceeds from the offering at US$103.3 million on the high end of the range.

The shares are expected to trade on the Nasdaq big board under the symbol “ABDC”. The underwriters also have a 30-day over-allotment option to purchase additional 1.0 million shares.

The proceeds from the offering are intended for investments in senior secured loans and general working capital purposes.

The finance firm services loans primarily to cannabis operators in the United States, including cultivators, processors, manufacturers, distributors, and retailers.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Eldorado Gold: The $3.8 Billion Foran Mining Acquisition

Silver Tiger’s $2.35B Silver Blueprint: Two Mines, One Perfect Metals Market

Gold Is At Records. Barrick Mining Is Printing Cash. The Stock Still Fell. | Q4 Earnings

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on...

Saturday, May 21, 2022, 05:12:00 PM

India-Focused Tech SPAC Cartica Acquisition Prices US$200 Million IPO

Special purpose acquisition company Cartica Acquisition Corp. (Nasdaq: CITEU) started trading on the Nasdaq Global...

Wednesday, January 5, 2022, 02:17:00 PM

Biotech Firm PepGen Prices US$108 Million IPO

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on...

Monday, May 9, 2022, 02:27:00 PM

It’s Been A Painful Year For IPOs, Proceeds Are Down 93%

It hasn’t been a good year for companies going public  — uncertainty from mounting recession...

Monday, December 5, 2022, 03:06:00 PM

Payfare Completes $65.4 Million IPO, To Begin Trading This Morning

Payfare Inc (TSX: PAY) has completed its initial public offering this morning, raising gross proceeds...

Friday, March 19, 2021, 09:25:08 AM